KREHER NERISSA

CIK 00017418504 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001741850

Recent Transactions

50 trades

Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2026-07-01+33,582→ 33,582 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2026-07-01$8.00/sh+37,910→ 37,910 total
Award
Rezolute, Inc.$RZLT
Common Shares
2025-11-19+21,000→ 58,576 total
Award
Rezolute, Inc.$RZLT
Director Stock Option (Right to Buy)
2025-11-19+12,000→ 12,000 total
Purchase
Rezolute, Inc.$RZLT
Common Shares
2025-06-13$3.25/sh+3,076→ 37,576 total
Award
Rezolute, Inc.$RZLT
Director Stock Options (Right to Buy)
2025-06-10+5,000→ 5,000 total
Award
Rezolute, Inc.$RZLT
Common Shares
2025-06-10+9,000→ 34,500 total
Award
Rezolute, Inc.$RZLT
Director Stock Option (Right to Buy)
2025-02-16+15,000→ 15,000 total
Award
Rezolute, Inc.$RZLT
Common Shares
2025-02-16+25,500→ 25,500 total
Award
Rezolute, Inc.$RZLT
Director Stock Options (Right to Buy)
2024-01-23+30,000→ 30,000 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-06$13.46/sh−871→ 40,058 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-06$14.00/sh−21→ 40,037 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-05$14.46/sh−401→ 40,929 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-01+14,200→ 41,330 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-09-01+21,500→ 21,500 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-08-04$2.10/sh+6,898→ 34,028 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-08-04−6,898→ 88,012 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-08-04$14.14/sh−6,898→ 27,130 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-08-03$2.10/sh+9,464→ 36,594 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-08-03−9,464→ 94,910 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-08-03$14.74/sh−9,464→ 27,130 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-08-02$2.10/sh+10,348→ 37,478 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-08-02$15.09/sh−9,280→ 28,198 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-08-02$16.01/sh−1,000→ 27,198 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-08-02−10,348→ 104,374 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-08-02$16.82/sh−68→ 27,130 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-02$11.60/sh−945→ 42,971 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-02$11.22/sh−164→ 41,330 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-02$10.49/sh−1,477→ 41,494 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-03-01+43,000→ 43,000 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-03-01+21,500→ 21,500 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-01+14,200→ 27,130 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-01+28,400→ 43,916 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-12-30$13.45/sh−5,200→ 15,516 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-26$22.01/sh−4,317→ 20,716 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-26$21.21/sh−643→ 25,033 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2022-10-26−4,960→ 114,722 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-26$2.10/sh+4,960→ 25,676 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-25$20.53/sh−4,942→ 23,814 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-25$22.13/sh−100→ 20,716 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2022-10-25−8,040→ 119,682 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-25$2.10/sh+8,040→ 28,756 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-25$21.42/sh−2,998→ 20,816 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-28$2.10/sh+3,122→ 23,838 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-28$15.25/sh−3,122→ 20,716 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2022-09-28−3,122→ 16,032 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-27$2.10/sh+2,403→ 23,119 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2022-09-27−2,403→ 19,154 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-27$15.31/sh−2,403→ 20,716 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-26$16.33/sh−300→ 20,716 total

Companies

Recent Filings

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607

View on SEC.gov